• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于HPPH介导的胸膜光动力疗法的光剂量测定

light dosimetry for HPPH-mediated pleural PDT.

作者信息

Dimofte Andreea, Zhu Timothy C, Finlay Jarod C, Cullighan Melissa, Edmonds Christine E, Friedberg Joseph S, Cengel Keith, Hahn Stephen M

机构信息

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA.

Department of Surgery, University of Pennsylvania, Philadelphia, PA.

出版信息

Proc SPIE Int Soc Opt Eng. 2010 Mar 4;7551. doi: 10.1117/12.851514.

DOI:10.1117/12.851514
PMID:26005243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4438784/
Abstract

This study examines the light fluence (rate) delivered to patients undergoing pleural PDT as a function of treatment time, treatment volume and surface area. The accuracy of treatment delivery is analyzed as a function of the calibration accuracies of each isotropic detector and the calibration integrating sphere. The patients studied here are enrolled in a Phase I clinical trial of HPPH-mediated PDT for the treatment of non-small cell lung cancer with pleural effusion. Patients are administered 4mg per kg body weight HPPH 24-48 hours before the surgery. Patients undergoing photodynamic therapy (PDT) are treated with light therapy with a fluence of 15-60 J/cm at 661nm. Fluence rate (mW/cm) and cumulative fluence (J/cm) is monitored at 7 different sites during the entire light treatment delivery. Isotropic detectors are used for in-vivo light dosimetry. The anisotropy of each isotropic detector was found to be within 15%. The mean fluence rate delivery and treatment time are recorded. A correlation between the treatment time and the treatment volume is established. The result can be used as a clinical guideline for future pleural PDT treatment.

摘要

本研究考察了接受胸膜光动力疗法(PDT)的患者所接受的光通量(率)与治疗时间、治疗体积和表面积之间的函数关系。分析了治疗剂量的准确性与每个各向同性探测器及校准积分球校准精度之间的函数关系。此处所研究的患者参加了一项采用HPPH介导的光动力疗法治疗伴有胸腔积液的非小细胞肺癌的I期临床试验。患者在手术前24 - 48小时按每公斤体重4毫克的剂量给予HPPH。接受光动力疗法(PDT)的患者采用661纳米波长、通量为15 - 60 J/cm²的光疗进行治疗。在整个光治疗过程中,在7个不同部位监测通量率(mW/cm²)和累积通量(J/cm²)。各向同性探测器用于体内光剂量测定。发现每个各向同性探测器的各向异性在15%以内。记录平均通量率和治疗时间。建立治疗时间与治疗体积之间的相关性。该结果可作为未来胸膜光动力疗法治疗的临床指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/56ed1b61bc32/nihms682594f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/f756ff44d9ed/nihms682594f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/acdec4b66ff9/nihms682594f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/eff6bb381ea5/nihms682594f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/56ed1b61bc32/nihms682594f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/f756ff44d9ed/nihms682594f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/acdec4b66ff9/nihms682594f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/eff6bb381ea5/nihms682594f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a8c/4438784/56ed1b61bc32/nihms682594f4.jpg

相似文献

1
light dosimetry for HPPH-mediated pleural PDT.用于HPPH介导的胸膜光动力疗法的光剂量测定
Proc SPIE Int Soc Opt Eng. 2010 Mar 4;7551. doi: 10.1117/12.851514.
2
Light dosimetry for pleural PDT.用于胸膜光动力疗法的光剂量测定
Proc SPIE Int Soc Opt Eng. 2009 Jan 24;7164. doi: 10.1117/12.809548.
3
Light dosimetry and dose verification for pleural PDT.胸膜光动力疗法的光剂量测定与剂量验证
Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8568. doi: 10.1117/12.2004941.
4
A Treatment Planning System for Pleural PDT.一种用于胸膜光动力疗法的治疗计划系统。
Proc SPIE Int Soc Opt Eng. 2010 Mar 2;7551. doi: 10.1117/12.843044.
5
Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.胸腔 Photofrin 介导光动力疗法的临床 PDT 剂量计量学。
J Biomed Opt. 2024 Jan;29(1):018001. doi: 10.1117/1.JBO.29.1.018001. Epub 2024 Jan 13.
6
Real-time PDT Dose Dosimetry for Pleural Photodynamic Therapy.用于胸膜光动力治疗的实时光动力疗法剂量测定法
Proc SPIE Int Soc Opt Eng. 2022 Jan-Feb;11940. doi: 10.1117/12.2612188. Epub 2022 Mar 4.
7
An IR navigation system for real-time treatment guidance of Pleural PDT.一种用于胸膜光动力疗法实时治疗引导的红外导航系统。
Proc SPIE Int Soc Opt Eng. 2011 Feb 28;7886. doi: 10.1117/12.875635.
8
A quality assurance program for clinical PDT.临床光动力疗法的质量保证计划。
Proc SPIE Int Soc Opt Eng. 2018 Mar;10476. doi: 10.1117/12.2288561.
9
Evaluation of Light Fluence Distribution Using an IR Navigation System for HPPH-mediated Pleural Photodynamic Therapy (pPDT).利用 IR 导航系统评估 HPPH 介导的胸膜光动力疗法(pPDT)中的光辐照度分布。
Photochem Photobiol. 2020 Mar;96(2):310-319. doi: 10.1111/php.13166. Epub 2019 Oct 22.
10
PDT dose dosimetry for pleural photodynamic therapy.用于胸膜光动力疗法的光动力疗法剂量测定法
Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8568. doi: 10.1117/12.2005198.

引用本文的文献

1
Comprehensive reanalysis of light fluence distribution in pleural photodynamic therapy using standardized anatomical coordinates.使用标准化解剖坐标对胸膜光动力疗法中的光通量分布进行综合再分析。
Photochem Photobiol. 2025 Jan 21. doi: 10.1111/php.14063.
2
AAPM Task Group Report 274: Fluence rate dosimetry for photodynamic therapy (PDT).美国医学物理师协会任务组报告274:光动力疗法(PDT)的注量率剂量测定法
Med Phys. 2025 Mar;52(3):1354-1371. doi: 10.1002/mp.17613. Epub 2025 Jan 15.
3
A real-time IR navigation system for pleural photodynamic therapy with a 3D surface acquisition system.一种用于胸膜光动力治疗的实时红外导航系统,带有三维表面采集系统。
Proc SPIE Int Soc Opt Eng. 2023 Jan-Feb;12359. doi: 10.1117/12.2650456. Epub 2023 Mar 14.
4
An Optical Surface Applicator for Intraoperative Photodynamic Therapy.一种用于术中光动力疗法的光学表面敷贴器。
Lasers Surg Med. 2020 Jul;52(6):523-529. doi: 10.1002/lsm.23168. Epub 2019 Oct 6.
5
Validation of tissue optical properties measurement using diffuse reflectance spectroscopy (DRS).使用漫反射光谱法(DRS)对组织光学特性测量进行验证。
Proc SPIE Int Soc Opt Eng. 2019 Feb;10860. doi: 10.1117/12.2513558. Epub 2019 Feb 28.
6
Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.肿瘤累及的小鼠胸腔治疗后光动力疗法疗效及表皮生长因子受体激活中的光通量率差异
Int J Mol Sci. 2016 Jan 14;17(1):101. doi: 10.3390/ijms17010101.
7
Light dosimetry and dose verification for pleural PDT.胸膜光动力疗法的光剂量测定与剂量验证
Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8568. doi: 10.1117/12.2004941.
8
PDT dose dosimetry for pleural photodynamic therapy.用于胸膜光动力疗法的光动力疗法剂量测定法
Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8568. doi: 10.1117/12.2005198.
9
An IR Navigation System for Pleural PDT.用于胸膜光动力疗法的红外导航系统。
Front Phys. 2015 Mar;3. doi: 10.3389/fphy.2015.00009.
10
A review of in-vivo optical properties of human tissues and its impact on PDT.人体组织的体内光学特性及其对 PDT 的影响综述。
J Biophotonics. 2011 Nov;4(11-12):773-87. doi: 10.1002/jbio.201100062.

本文引用的文献

1
Diffuse reflectance spectra measured in human tissues during Photofrin-mediated pleural photodynamic therapy.在血卟啉单甲醚介导的胸膜光动力治疗期间测量的人体组织漫反射光谱。
Proc SPIE Int Soc Opt Eng. 2006 Jan 21;6139. doi: 10.1117/12.647016.
2
Light dosimetry for pleural PDT.用于胸膜光动力疗法的光剂量测定
Proc SPIE Int Soc Opt Eng. 2009 Jan 24;7164. doi: 10.1117/12.809548.
3
Hemoglobin oxygen saturations in phantoms and in vivo from measurements of steady-state diffuse reflectance at a single, short source-detector separation.通过在单个短源-探测器间距下测量稳态漫反射来获取模型和体内的血红蛋白氧饱和度。
Med Phys. 2004 Jul;31(7):1949-59. doi: 10.1118/1.1760188.
4
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread.胸膜光动力疗法联合手术治疗非小细胞肺癌胸膜转移患者的II期试验
J Clin Oncol. 2004 Jun 1;22(11):2192-201. doi: 10.1200/JCO.2004.07.097.
5
In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer.用于莫替沙芬镥介导的复发性乳腺癌光动力疗法的体内光剂量测定
Lasers Surg Med. 2002;31(5):305-12. doi: 10.1002/lsm.10115.